Alloimmunization in patients with sickle cell disease and thalassemia: Experience of a single centre in oman

Medicine and Dentistry

• Alloimmunization 100%
• Sickle-Cell Disease 83%
• Antibody 66%
• Transfusion 50%
• Sickle Cell Beta Thalassemia 50%
• Patient with Sickle Cell Disease 33%
• Thalassemia 33%
• Blood Transfusion 16%
• Complication 16%
• Prevalence 16%
• Phenotype 16%
• Blood Group Kell System 16%
• Rhesus Antigen 16%
• Matched Donor 16%
• Supportive Care 16%

Immunology and Microbiology

• Sickle Cell 100%
• Monospecific Antibody 57%
• Prevalence 14%
• Phenotype 14%
• Blood Transfusion 14%
• Blood Group Kell System 14%
• Rhesus Antigen 14%

Agricultural and Biological Sciences

• Antibodies 57%
• Prevalence 14%
• Blood Transfusion 14%